To send content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about sending content to .
To send content items to your Kindle, first ensure firstname.lastname@example.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about sending to your Kindle.
Note you can select to send to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
This chapter summarizes the current knowledge on prevalence and characteristics of cerebral microbleeds (CMBs) in normal individuals. The most solid knowledge on CMBs comes from the population-based studies, in particular those that have included higher age groups and have used a sensitive technique to detect CMBs. The four population-based studies with reported findings on CMBs in normal individuals are the Austrian Stroke Prevention Study, the Framingham Study, the Age Gene/Environment Susceptibility (AGES)-Reykjavik study (AGES-R) and the Rotterdam Scan Study. A pioneering study from Japan studied the prevalence of CMBs in 450 neurologically healthy Japanese adults with a mean age of 52.9 years. The overall incidence was 3.1% (14/450), and lesions detected were closely related to hypertension and heavy cigarette smoking. Patterns of risk factors and comorbidities are different between regions, and one can assume that such factors should also affect prevalence rates of CMBs.